Remarkably, the beneficial effects of replacement therapy with oral Sucrosomial® iron on both Hb increment (Fig. 2A) and anemia correction (Fig. 2B) were observed as early as 10 day after treatment initiation. Here, GSTM1 is linked to anemia (phenotype).